CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 97.61 Thousand USD | -91.99% |
| 2020 | 1.21 Million USD | 0.79% |
| 2019 | 1.2 Million USD | -12.5% |
| 2018 | 1.38 Million USD | -19.75% |
| 2017 | 1.72 Million CAD | 41.88% |
| 2016 | 1.21 Million CAD | 11042.82% |
| 2015 | 10.89 Thousand CAD | 106.99% |
| 2014 | 5265.06 CAD | -62.88% |
| 2013 | 14.18 Thousand CAD | -89.21% |
| 2012 | 131.5 Thousand CAD | 385.75% |
| 2011 | 27.07 Thousand CAD | 41.83% |
| 2010 | 19.08 Thousand CAD | -40.54% |
| 2009 | 32.1 Thousand CAD | 350.57% |
| 2008 | 7124.90 CAD | -99.81% |
| 2007 | 3.76 Million CAD | 107.52% |
| 2006 | 1.81 Million CAD | 276.4% |
| 2005 | 482.34 Thousand CAD | 257.6% |
| 2004 | 134.88 Thousand CAD | 8.88% |
| 2003 | 123.88 Thousand CAD | -70.25% |
| 2002 | 416.43 Thousand CAD | -5.06% |
| 2001 | 438.64 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 34.07 Thousand USD | 61.63% |
| 2022 Q3 | 8595.00 USD | -74.78% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q1 | 21.08 Thousand USD | -78.4% |
| 2021 Q4 | 97.61 Thousand USD | -91.96% |
| 2021 Q2 | 1.25 Million USD | 1.45% |
| 2021 Q1 | 1.23 Million USD | 1.26% |
| 2021 Q3 | 1.21 Million USD | -3.02% |
| 2021 FY | 97.61 Thousand USD | -91.99% |
| 2020 Q3 | 1.18 Million USD | -1.94% |
| 2020 Q1 | 1.1 Million USD | -8.86% |
| 2020 Q4 | 1.21 Million USD | 3.13% |
| 2020 Q2 | 1.2 Million USD | 9.36% |
| 2020 FY | 1.21 Million USD | 0.79% |
| 2019 Q3 | 1.31 Million USD | -3.07% |
| 2019 Q4 | 1.2 Million USD | -7.99% |
| 2019 FY | 1.2 Million USD | -12.5% |
| 2019 Q1 | 1.9 Million USD | 37.97% |
| 2019 Q2 | 1.35 Million USD | -28.89% |
| 2018 Q4 | 1.38 Million USD | 7.04% |
| 2018 Q1 | 1.34 Million CAD | -22.04% |
| 2018 Q2 | 1.28 Million CAD | -4.28% |
| 2018 Q3 | 1.29 Million CAD | 0.46% |
| 2018 FY | 1.38 Million USD | -19.75% |
| 2017 Q2 | 3.13 Million CAD | 97.58% |
| 2017 Q3 | 3.18 Million CAD | 1.35% |
| 2017 Q1 | 1.58 Million CAD | 30.81% |
| 2017 FY | 1.72 Million CAD | 41.88% |
| 2017 Q4 | 1.72 Million CAD | -45.84% |
| 2016 Q3 | 2.71 Million CAD | 46966.0% |
| 2016 FY | 1.21 Million CAD | 11042.82% |
| 2016 Q1 | 5885.80 CAD | -45.99% |
| 2016 Q2 | 5759.09 CAD | -2.15% |
| 2016 Q4 | 1.21 Million CAD | -55.2% |
| 2015 Q2 | 4181.07 CAD | -13.3% |
| 2015 Q1 | 4822.53 CAD | -8.41% |
| 2015 FY | 10.89 Thousand CAD | 106.99% |
| 2015 Q4 | 10.89 Thousand CAD | 122.32% |
| 2015 Q3 | 4902.05 CAD | 17.24% |
| 2014 FY | 5265.06 CAD | -62.88% |
| 2014 Q2 | 8396.37 CAD | -53.47% |
| 2014 Q1 | 18.04 Thousand CAD | 27.23% |
| 2014 Q3 | 5330.68 CAD | -36.51% |
| 2014 Q4 | 5265.06 CAD | -1.23% |
| 2013 Q4 | 14.18 Thousand CAD | -80.83% |
| 2013 FY | 14.18 Thousand CAD | -89.21% |
| 2013 Q3 | 74 Thousand CAD | -25.68% |
| 2013 Q2 | 99.58 Thousand CAD | 21.66% |
| 2013 Q1 | 81.84 Thousand CAD | -37.76% |
| 2012 Q3 | 180.33 Thousand CAD | 3937.48% |
| 2012 Q4 | 131.5 Thousand CAD | -27.08% |
| 2012 Q1 | 25.01 Thousand CAD | -7.59% |
| 2012 FY | 131.5 Thousand CAD | 385.75% |
| 2012 Q2 | 4466.62 CAD | -82.15% |
| 2011 Q3 | 28.96 Thousand CAD | 147.31% |
| 2011 Q4 | 27.07 Thousand CAD | -6.54% |
| 2011 FY | 27.07 Thousand CAD | 41.83% |
| 2011 Q1 | 21.34 Thousand CAD | 11.81% |
| 2011 Q2 | 11.71 Thousand CAD | -45.12% |
| 2010 Q4 | 19.08 Thousand CAD | 0.0% |
| 2010 FY | 19.08 Thousand CAD | -40.54% |
| 2009 FY | 32.1 Thousand CAD | 350.57% |
| 2008 Q2 | 3.81 Million CAD | 1.18% |
| 2008 FY | 7124.90 CAD | -99.81% |
| 2008 Q4 | 7124.90 CAD | -93.81% |
| 2008 Q1 | 3.77 Million CAD | 0.11% |
| 2008 Q3 | 115.18 Thousand CAD | -96.98% |
| 2007 Q4 | 3.76 Million CAD | 9.9% |
| 2007 FY | 3.76 Million CAD | 107.52% |
| 2007 Q1 | 2.93 Million CAD | 61.75% |
| 2007 Q2 | 3.27 Million CAD | 11.6% |
| 2007 Q3 | 3.42 Million CAD | 4.61% |
| 2006 Q2 | 1.54 Million CAD | 17.3% |
| 2006 Q4 | 1.81 Million CAD | -15.33% |
| 2006 FY | 1.81 Million CAD | 276.4% |
| 2006 Q3 | 2.14 Million CAD | 38.64% |
| 2006 Q1 | 1.31 Million CAD | 173.37% |
| 2005 Q3 | 550.26 Thousand CAD | 203.74% |
| 2005 Q4 | 482.34 Thousand CAD | -12.34% |
| 2005 Q2 | 181.16 Thousand CAD | 32.0% |
| 2005 Q1 | 137.24 Thousand CAD | 1.75% |
| 2005 FY | 482.34 Thousand CAD | 257.6% |
| 2004 Q2 | 164.34 Thousand CAD | 42.71% |
| 2004 Q3 | 149.84 Thousand CAD | -8.82% |
| 2004 Q4 | 134.88 Thousand CAD | -9.98% |
| 2004 FY | 134.88 Thousand CAD | 8.88% |
| 2004 Q1 | 115.15 Thousand CAD | -7.05% |
| 2003 Q3 | 390.05 Thousand CAD | -6.91% |
| 2003 Q4 | 123.88 Thousand CAD | -68.24% |
| 2003 FY | 123.88 Thousand CAD | -70.25% |
| 2003 Q1 | 414.71 Thousand CAD | -0.41% |
| 2003 Q2 | 418.99 Thousand CAD | 1.03% |
| 2002 Q2 | 369.58 Thousand CAD | -2.49% |
| 2002 FY | 416.43 Thousand CAD | -5.06% |
| 2002 Q1 | 379.01 Thousand CAD | 0.0% |
| 2002 Q4 | 416.43 Thousand CAD | 12.94% |
| 2002 Q3 | 368.72 Thousand CAD | -0.23% |
| 2001 FY | 438.64 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 100.0% |
| BioElectronics Corporation | 144.38 Thousand USD | 100.0% |
| IR-Med Inc. | 999 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 100.0% |
| Polarean Imaging plc | 10.86 Million USD | 100.0% |
| AVITA Medical, Inc. | 144.33 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | 100.0% |
| Össur hf. | 1.39 Billion USD | 100.0% |
| Zecotek Photonics Inc. | 2.57 Million USD | 100.0% |
| QHSLab, Inc. | 1.68 Million USD | 100.0% |
| Wellstar International, Inc. | 957.89 Thousand USD | 100.0% |
| Össur hf. | 1.39 Billion USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 100.0% |
| Escalon Medical Corp. | 4.75 Million USD | 100.0% |
| Aurora Spine Corporation | 11.92 Million USD | 100.0% |
| BrainsWay Ltd. | 62.97 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 2.85 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 100.0% |
| Vivos Inc. | 1.61 Million USD | 100.0% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 1.63 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | 100.0% |
| Nanomix Corporation | 982.05 Thousand USD | 100.0% |
| Theraclion SA | 18.66 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | 100.0% |
| Positron Corporation | 1.76 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 100.0% |
| Lombard Medical, Inc. | 67.76 Million USD | 100.0% |
| ALR Technologies Inc. | 193.21 Thousand USD | 100.0% |
| Stratec SE | 529.71 Million USD | 100.0% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 100.0% |
| Heart Tronics, Inc. | 4.04 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 4.45 USD | 100.0% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 100.0% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 100.0% |
| United American Healthcare Corporation | 10.37 Million USD | 100.0% |
| ECGI Holdings, Inc. | 5.2 Million USD | 100.0% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 100.0% |
| Urologix, Inc. | 5.66 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 100.0% |
| SS Innovations International, Inc. | 25.47 Million USD | 100.0% |
| Qualis Innovations, Inc. | 2431.00 USD | 100.0% |
| Smith & Nephew plc | 9.97 Billion USD | 100.0% |
| NIOX Group Plc | 116.47 Million USD | 100.0% |
| Fuse Medical, Inc. | 16.25 Million USD | 100.0% |
| Broncus Holding Corporation | 195.75 Million USD | 100.0% |
| Brain Scientific Inc. | 11.74 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 100.0% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | 100.0% |